Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
b8QMLak28nExu7C1